Genomma Lab Internacional, S.A.B. de C.V. Stock
Stocks
LAB B
MX01LA010006
Pharmaceuticals
OTC Markets Traded|
End-of-day quote
Mexican S.E.
2026-08-14
|
5-day change | 1st Jan Change | ||
| 13.71 MXN | -0.80% |
|
-4.53% | -23.37% |
| Market Cap | 13.37B 786M 679M 638M 580M 1.09B 75.14B 1.11B 7.47B 2.92B 37.63B 2.95B 2.89B 125B | P/E 2026 * |
5.36x | P/E 2027 * | 6.43x |
|---|---|---|---|---|---|
| Enterprise Value | 17.82B 1.05B 905M 850M 773M 1.45B 100B 1.48B 9.96B 3.89B 50.16B 3.93B 3.85B 167B | EV / Sales 2026 * |
0.95x | EV / Sales 2027 * | 0.88x |
| Free-Float |
68.95% | Yield 2026 * |
6.08% | Yield 2027 * | 8.98% |
Last Transcript: Genomma Lab Internacional, S.A.B. de C.V.
| 1 day | -0.80% | ||
| 1 week | -4.53% | ||
| Current month | -6.61% | ||
| 1 month | -9.08% | ||
| 3 months | -14.90% | ||
| 6 months | -23.54% | ||
| Current year | -23.37% |
| 1 week | 13.54 |  | 14.31 |
| 1 month | 13.54 | | 15.11 |
| Current year | 13.54 | | 19.48 |
| 1 year | 13.54 | | 23.2 |
| 3 years | 12.39 | | 29.18 |
| 5 years | 12.39 | | 29.18 |
| 10 years | 11.1 | | 29.18 |
| Manager | Title | Age | Since |
|---|---|---|---|
Marco Sparvieri
CEO | Chief Executive Officer | - | 2023-04-11 |
| Director of Finance/CFO | - | 2015-11-30 | |
| Investor Relations Contact | - | 2019-09-30 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | - | 1996-10-29 | |
Juan Alonso
BRD | Director/Board Member | - | 2010-07-05 |
| Director/Board Member | - | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.80% | -4.53% | -36.11% | -4.53% | 786M | |
| -2.25% | -0.47% | +72.43% | +119.36% | 1,052B | |
| -0.66% | +0.43% | +49.01% | +50.11% | 627B | |
| -0.54% | +1.39% | +21.88% | +63.83% | 441B | |
| -1.99% | -3.32% | +41.98% | +34.08% | 349B | |
| -1.05% | -2.81% | +24.22% | +34.67% | 287B | |
| -2.12% | -3.67% | -1.09% | +3.11% | 241B | |
| -0.63% | +1.04% | +43.03% | +59.10% | 224B | |
| -1.19% | -3.41% | -9.18% | -52.41% | 202B | |
| +0.16% | +3.87% | +16.25% | +73.27% | 172B | |
| Average | -0.67% | +0.03% | +22.24% | +38.06% | 359.6B | |
| Weighted average by Cap. | -0.09% | +0.31% | +41.30% | +62.01% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 18.72B 1.1B 951M 893M 812M 1.53B 105B 1.55B 10.47B 4.09B 52.7B 4.13B 4.04B 175B | 19.19B 1.13B 974M 916M 833M 1.57B 108B 1.59B 10.73B 4.19B 54.02B 4.24B 4.14B 180B |
| Net income | 2.19B 129M 111M 105M 95.19M 179M 12.33B 182M 1.23B 480M 6.18B 484M 474M 20.52B | 2.18B 128M 111M 104M 94.46M 178M 12.24B 181M 1.22B 476M 6.13B 480M 470M 20.36B |
| Net Debt | 4.45B 262M 226M 212M 193M 363M 25.03B 369M 2.49B 973M 12.53B 983M 961M 41.65B | 3.56B 209M 181M 170M 154M 290M 20B 295M 1.99B 778M 10.02B 785M 768M 33.29B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-14 | MX$13.71 | -0.80% | 1,996,078 |
| 26-08-13 | MX$13.82 | -1.64% | 1,440,992 |
| 26-08-12 | MX$14.05 | +0.07% | 1,554,147 |
| 26-08-11 | MX$14.04 | -1.27% | 1,793,825 |
| 26-08-10 | MX$14.22 | -0.97% | 1,099,349 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- LAB B Stock
Select your edition
All financial news and data tailored to specific country editions
